Investment Opportunities

Where to find financial help

Listed below you’ll discover various funds you can apply to for supporting the development and commercialisation of your promising technology.

Simply click on a fund to read more about the support it provides, the criteria it applies in doing so and how you can find more information or apply for help.

UCL Technology Fund

The UCL Technology Fund is dedicated to investing in intellectual property commercialisation opportunities arising from UCL’s world-class research base, focusing in particular on the physical and life sciences. The Fund will support academics throughout UCL in achieving the full potential of innovations that have prospects for outstanding societal and market impact, right through the development journey from initial proof of concept to practical application.

The Fund is able to invest in opportunities drawn from across UCL’s research base and aims to support commercialisation by providing appropriate funding and commercial support. The Fund’s unique approach includes early stage proof-of-concept funding, development funding to achieve successful licensing outcomes, and funding for spin-out companies to take opportunities through to market.

Backed by leading venture investors – the European Investment Fund, Imperial Innovations and Albion Ventures – as well as UCL’s technology transfer business, UCLB, the Fund has a long-term and progressive attitude to funding, with direct access to follow-on investment. It is managed jointly by UCLB and Albion Ventures.

For more information, please visit: www.ucltf.co.uk

Apollo Therapeutics

The Apollo Therapeutics Fund is a unique collaboration between three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline and Johnson & Johnson) and the technology transfer offices (TTOs) responsible for commercialising the research from Imperial College London, UCL and the University of Cambridge. The £40m fund will provide translational research funding for early-stage therapeutics projects arising from the three universities.

This is the first time that three global pharmaceutical companies and the TTOs of three world-leading universities have come together to form a joint enterprise of this nature, making the Apollo Therapeutics Fund a truly innovative venture.

It not only provides an additional source of early-stage funding that will allow more projects to be progressed, but also involves the active participation of the industry partners, bringing commercial drug development expertise. Projects will be shaped at a very early stage to optimise the chances of onward development.

For further information, please visit: apollotherapeutics.com

NEED ADVICE?

For a confidential, no obligation discussion about the possibilities and opportunities for your novel idea, please contact your Business Manager.